Eli Lilly and Co - reuters.com

Get Eli Lilly and Co (LLY) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsLLY - | Stock Price & Latest News | ReutersEli Lilly and Co LLY. Official Data Partner. Latest Trade. trading higher 725.72 US…Eli Lilly and Co | ReutersThe latest international Eli Lilly and Co news and views from Reuters - one of t…LLY.N - | Stock Price & Latest News | ReutersGet Eli Lilly and Co (LLY.N) real-time stock quotes, news, price and financial …Exclusive: U.S. finds new quality problems at Lilly drug factoryU.S. drug inspectors recently recorded several new quality- control problems a…Lilly needs a plan to spur weight-loss drug sales, investors sayFeb 5 (Reuters) - Eli Lilly (LLY.N), opens new tab investors and analysts said the…Lilly hits record high after Mounjaro fuels forecast raise, rival dataEli Lilly on Tuesday raised its annual forecasts as demand for new diabetes …

CouponFollow Extension

22%
OFF

Eli Lilly Bulls Take Charge Ahead Of Q4 — Can It Reach $1000?

3 weeks from now

11 hours ago · Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for further gains. Analysts see 27% upside.

benzinga.com

$1020.00
OFF

Eli Lilly & Co (LLY) Gets A Buy From Jefferies - Markets Insider

3 weeks from now

17 hours ago · Jefferies analyst Akash Tewari maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on February 3 and set a price target of $1,020.00. The company’s shares …

businessinsider.com

$732
OFF

Eli Lilly's SWOT Analysis: Stock Poised For Growth Amid Challenges

3 weeks from now

3 days ago · Eli Lilly and Company (NYSE: LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been making waves in the biopharmaceutical industry with its …

investing.com

FAQs about Eli Lilly and Co - reuters.com Coupon?

Does Eli Lilly have quality control problems?

REUTERS/Mike Segar Purchase Licensing Rights Oct 11 (Reuters) - U.S. drug inspectors recently recorded several new quality- control problems at an Eli Lilly and Co (LLY.N) plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters. ...

Are new quality control problems at Eli Lilly a federal investigation?

U.S. drug inspectors recently recorded several new quality- control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters. ...

How much revenue does Eli Lilly expect in 2024?

INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, which represents growth of 32% compared to the previous year. ...

Does Eli Lilly have a demand problem?

David Ricks, Eli Lilly’s chief executive, said the company had faced “a lot of lumpiness” in demand from wholesalers because of changing stock levels, but that he expected demand would accelerate with a US advertising push and international launches. “At a macro level, is there a demand problem here actually? No. Is there a supply problem? ...

When will Eli Lilly & Co (LLY) announce financial results?

Image by Mohammed_Al_Ali via Shutterstock Eli Lilly And Co (NYSE:LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on February 6. As per data from Benzinga Pro, the Wall Street estimates sales of $13.7 billion, with adjusted EPS of $4.94. ...

What is Eli Lilly & Company?

As of Jan 30, 2025. Values delayed up to 15 minutes Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. ...